Status:
UNKNOWN
S Protein and COVID-19: a Monocentric Prospective Study
Lead Sponsor:
University of Milano Bicocca
Collaborating Sponsors:
San Gerardo Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to compare plasma S Protein levels to SARS-CoV-2 viral load in COVID positive patients.
Detailed Description
Non-pharmacological, non-interventional, prospective, monocentric study involving the use of biological materials. There will be two cohorts: * COVID + cohort: 50 patients with positive nasopharynge...
Eligibility Criteria
Inclusion
- Cohort COVID + :
- Subjects aged ≥ 18 years.
- Signing of the informed consent.
- Positivity for SARS-CoV-2 by RealTimePCR from nasopharyngeal swab or bronchial wash.
- Cohort Control:
- Subjects aged ≥ 18 years.
- Signing of the informed consent.
- Diagnosis of pneumonia not related to SARS-CoV-2, demonstrated by negative swab.
Exclusion
- Patients with a diagnosis of congenital S Protein deficiency.
- Patients who are taking oral anticoagulant therapy (TAO) or new oral anticoagulants (NAO).
- Chronic liver failure (\> 5 points on the Child-Pugh score).
- Female subjects who are pregnant or on estrogen-progestogen replacement therapy.
Key Trial Info
Start Date :
September 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 3 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05351385
Start Date
September 23 2021
End Date
December 3 2024
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Gerardo Hospital
Monza, Lombardy, Italy, 20900